Literature DB >> 28918395

Non-invasive high-frequency oscillatory ventilation in preterm infants: a randomised controlled cross-over trial.

Daniel Klotz1, Hendryk Schneider1, Stefan Schumann2, Benjamin Mayer3, Hans Fuchs1.   

Abstract

OBJECTIVE: Non-invasive high-frequency oscillatory ventilation (nHFOV) has recently been described as a novel mode of respiratory support for premature infants. This study was designed to determine whether nHFOV decreases CO2 partial pressure (pCO2) in premature infants more effectively than non-invasive continuous positive airway pressure (nCPAP).
DESIGN: Non-blinded prospective randomised controlled cross-over study.
SETTING: University Medical Center tertiary neonatal intensive care unit. PATIENTS: 26 premature infants of 27±2 weeks of gestational age after extubation or non-invasive surfactant treatment.
INTERVENTIONS: Infants were treated with 4 hours of nHFOV and 4 hours of nCPAP in a cross-over design. The sequence of the ventilation mode was randomly allocated. MAIN OUTCOME MEASURES: The primary outcome measure was pCO2 of arterial or arterialised blood 4 hours after commencing the respective mode of respiratory support. Secondary outcome criteria included events of apnoea and bradycardia, respiratory rate, heart rate, pain and/or discomfort, mean airway pressure, fraction of inspired oxygen and failure of non-invasive respiratory support.
RESULTS: pCO2 after 4 hours of nHFOV was similar compared with 4 hours of nCPAP (p=0.33). pCO2 was 54.8 (14.6) vs 52.7 (9.3) mm Hg mean (SD) for the nHFOV-nCPAP period (n=13) and 49.0 (8.1) vs 47.7 (9.5) mm Hg for the nCPAP-nHFOV period (n=13). There was no difference in any of the secondary outcome measures. nHFOV was terminated prematurely in five cases for predefined failure criteria (p=0.051).
CONCLUSIONS: We could not demonstrate an increased carbon dioxide clearance applying nHFOV compared with nCPAP in this cohort of preterm infants. TRIAL REGISTRATION NUMBER: DRKS00007171, results. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  carbon dioxide; high frequency oscillatory ventilation; neonate; non-invasive ventilation; preterm

Mesh:

Substances:

Year:  2017        PMID: 28918395     DOI: 10.1136/archdischild-2017-313190

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  4 in total

1.  Noninvasive high-frequency oscillatory ventilation versus bi-level positive pressure ventilation in premature infants with respiratory failure: A retrospective study.

Authors:  Wenqian Chen; Zhiqing Chen; Shuhua Lai; Wenhong Cai; Yunfeng Lin
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

2.  Eligibility Criteria and Representativeness of Randomized Clinical Trials That Include Infants Born Extremely Premature: A Systematic Review.

Authors:  Leeann R Pavlek; Brian K Rivera; Charles V Smith; Joanie Randle; Cory Hanlon; Kristi Small; Edward F Bell; Matthew A Rysavy; Sara Conroy; Carl H Backes
Journal:  J Pediatr       Date:  2021-04-21       Impact factor: 6.314

3.  Non-invasive high-frequency oscillatory ventilation in preterm infants after extubation: a randomized, controlled trial.

Authors:  Yan Li; Qiufen Wei; Dan Zhao; Yan Mo; Liping Yao; Lingxiao Li; Wei Tan; Xinnian Pan; Jiayan Yao; Wei Dai; Danni Zhong
Journal:  J Int Med Res       Date:  2021-02       Impact factor: 1.671

4.  Nasal HFOV versus nasal IPPV as a post-extubation respiratory support in preterm infants-a randomised controlled trial.

Authors:  Soutrik Seth; Bijan Saha; Anindya Kumar Saha; Suchandra Mukherjee; Avijit Hazra
Journal:  Eur J Pediatr       Date:  2021-04-23       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.